Use of thymosin alpha 1 for the treatment of immunological diseases
AssigneeSigma-Tau Industrie Farmaceutiche Riunite S.p.A.
InventorsLuigina ROMANI, Francesco BISTONI, Enrico GARACI
Life of this patent
Estimating the term…
Abstract
It is described the use of thymosin alpha 1 for preparing a medicament useful for the prevention or treatment of graft-versus-host disease or graft rejection reactions in organ transplantation, in a mammal subject, in which the cells, tissues or organs for transplant is selected from the group comprising: stem cells, hematopoietic stem cells, bone marrow, heart, liver, kidney, lung, pancreas, small intestine, cornea or skin.
Claims16
Method of treating or inhibiting graft-versus-host disease or graft rejection reactions in organ transplantation in a mammal subject, comprising administering an effective amount of thymosin alpha 1.
Dependencies are inferred from the claim text.